The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com

PARTNER NEWS:

Thu, Apr 17, 10:32 AM, Zacks
AbbVie Candidate in Pivotal Study - Analyst Blog
AbbVie's experimental cancer drug veliparib has been moved into a pivotal study.

Thu, Apr 17, 8:46 AM, Zacks
Dow 30 Stock Roundup: JNJ Beats, JPM Disappoints - Analyst Blog
The Dow notched up substantial gains during a holiday shortened week, boosted by several positive factors.

Pfizer Inc (PFE)

Pfizer is a research-based biopharmaceutical company. Co.'s Primary Care segment includes products prescribed by primary-care physicians. Co.'s Specialty Care and Oncology segment includes products prescribed by physicians who are specialists. Co.'s Established Products and Emerging Markets segment includes products that have lost patent protection or marketing rights and those sold in emerging markets. Co.'s Animal Health segment includes products and services to address disease in livestock and companion animals. Co.'s Consumer Healthcare segment includes non-prescription products in several therapeutic categories.

Company Name:  Pfizer Inc
Website:  www.pfizer.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding PFE:  96
Total Market Value Held by ETFs:  $7.24B
Total Market Capitalization:  $192.06B
% of Market Cap. Held by ETFs:  3.77%

April 20, 2014    2:23 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Trade PFE Now:



Buy (3.14 out of 4)
57th percentile
(ranked higher than approx. 57% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Pfizer Inc (PFE) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.